tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HOWL Stock Latest News

Werewolf Therapeutics price target lowered to $4 from $12 at JMP Securities
The FlyWerewolf Therapeutics price target lowered to $4 from $12 at JMP Securities
5d ago
HOWL
Werewolf Therapeutics provides business update, highlights 2025 outlook
PremiumThe Fly
Werewolf Therapeutics provides business update, highlights 2025 outlook
5d ago
HOWL
Werewolf Therapeutics Advances Innovative Cytokine Therapies
PremiumCompany Announcements
Werewolf Therapeutics Advances Innovative Cytokine Therapies
2M ago
8K
HOWL
Werewolf Therapeutics presents preclinical, clinical data on WTX-330
PremiumThe Fly
Werewolf Therapeutics presents preclinical, clinical data on WTX-330
2M ago
HOWL
Werewolf Therapeutics reports Q3 EPS (38c), consensus (41c)
PremiumThe Fly
Werewolf Therapeutics reports Q3 EPS (38c), consensus (41c)
2M ago
HOWL
Werewolf Therapeutics sees cash runway through 2Q26
PremiumThe FlyWerewolf Therapeutics sees cash runway through 2Q26
2M ago
HOWL
Werewolf Therapeutics announces addition of WTX-921 to pipeline
Premium
The Fly
Werewolf Therapeutics announces addition of WTX-921 to pipeline
3M ago
HOWL
Bank of America Predicts up to ~390% Surge for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Bank of America Predicts up to ~390% Surge for These 2 ‘Strong Buy’ Stocks
3M ago
HOWL
IBTA
Werewolf Therapeutics reports Q2 EPS (43c), consensus (38c)
PremiumThe Fly
Werewolf Therapeutics reports Q2 EPS (43c), consensus (38c)
5M ago
HOWL
Werewolf Therapeutics Reports Promising WTX-330 Trial Outcomes
PremiumCompany Announcements
Werewolf Therapeutics Reports Promising WTX-330 Trial Outcomes
7M ago
8K
HOWL
Werewolf announces initial trial results evaluating INDUKINE for lymphoma
PremiumThe Fly
Werewolf announces initial trial results evaluating INDUKINE for lymphoma
7M ago
HOWL
Werewolf Therapeutics’ Promising WTX-124 Clinical Trial Outcomes
PremiumCompany Announcements
Werewolf Therapeutics’ Promising WTX-124 Clinical Trial Outcomes
8M ago
8K
HOWL
Werewolf Therapeutics presents data from ongoing Phase 1/1b trial of WTX-124
PremiumThe FlyWerewolf Therapeutics presents data from ongoing Phase 1/1b trial of WTX-124
8M ago
HOWL
Werewolf Therapeutics sees cash runway through at least 1Q26
Premium
The Fly
Werewolf Therapeutics sees cash runway through at least 1Q26
9M ago
HOWL
Werewolf Therapeutics reports Q1 EPS (39c), consensus (35c)
Premium
The Fly
Werewolf Therapeutics reports Q1 EPS (39c), consensus (35c)
9M ago
HOWL
Werewolf Therapeutics presents preclinical data on IL-10 INDUKINE molecules
PremiumThe Fly
Werewolf Therapeutics presents preclinical data on IL-10 INDUKINE molecules
9M ago
HOWL
Werewolf Therapeutics to present data from studies of WTX-518, WTX-712 at AACR
PremiumThe Fly
Werewolf Therapeutics to present data from studies of WTX-518, WTX-712 at AACR
10M ago
HOWL
Werewolf Therapeutics initiated with an Outperform at JMP Securities
PremiumThe Fly
Werewolf Therapeutics initiated with an Outperform at JMP Securities
10M ago
HOWL
Werewolf Therapeutics Announces CSO Retirement Date
PremiumCompany Announcements
Werewolf Therapeutics Announces CSO Retirement Date
11M ago
8K
HOWL
Werewolf Therapeutics expects cash to fund requirements through at least 2Q25
PremiumThe FlyWerewolf Therapeutics expects cash to fund requirements through at least 2Q25
11M ago
HOWL
Werewolf Therapeutics reports Q4 EPS (33c), consensus (43c)
Premium
The Fly
Werewolf Therapeutics reports Q4 EPS (33c), consensus (43c)
11M ago
HOWL
Werewolf Therapeutics Expands Offering with $25M Stock Sale
Premium
Company Announcements
Werewolf Therapeutics Expands Offering with $25M Stock Sale
11M ago
8K
HOWL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >